Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterisation of Gastric Residence of a Furosemide-containing New Gastric Retention System by Means of MMM Measurement and Determination of Pharmacokinetics, Pharmacodynamics and Safety

NCT01887379 is registered in ClinicalTrials.gov with LTS Lohmann Therapie-Systeme AG as lead sponsor.

NCT NCT01887379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01887379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterisation of Gastric Residence of a Furosemide-containing New Gastric Retention System by Means of MMM Measurement and Determination of Pharmacokinetics, Pharmacodynamics and Safety
Lead sponsor
LTS Lohmann Therapie-Systeme AG
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2013
Completion date
August 31, 2013
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroretentive drug formulation of furosemide, oedema